Fang, Liang <br/><br/>
GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells.  [electronic resource] 

 -  Oncology reports  Mar 2018 
 - 1283-1291 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2017.6161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Drug Synergism<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Guanine--analogs & derivatives<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mouth Neoplasms--drug therapy<br/>Peptide Initiation Factors--antagonists & inhibitors<br/>RNA-Binding Proteins--antagonists & inhibitors<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays<br/>Eukaryotic Translation Initiation Factor 5A